Aquavit Pharmaceuticals

Media

***PIRACY ALERT***

October 21, 2016

Dear Valued Customers and Partners of Aquavit:

RE: Illegal Piracy Activities in Korea and China

It has come to our attention that an illegal Korean operator has been marketing pirated copies of AQUAGOLD® fine touch™. You may find trade names such as Tappy Tok-Tok or Hydragold that appear similar to AQUAGOLD® fine touch™. However, these counterfeit units are of sub-par quality and do not follow the same GMP standards our company requires. In addition, they are operating with fake patents, certifications, and illegally using AQUAGOLD® trademarks to market in Asia and through the internet.



Continue Reading...

A.S.A.P. Inc. (Advanced Skin Application Platform) Becomes an Affiliate of Aquavit

Las Vegas, NEVADA, Oct 20, 2016

Aquavit has today signed on A.S.A.P. Inc., as one of its affiliate partners. A.S.A.P., Inc. is a Nevada corporation dedicated to personalized skin health and solutions, and is developing and delivering technologies that promote healthy looking skin./p>

Continue Reading...

Message to AQUAGOLD customers

New York, NEW YORK, May 4, 2016

Dear Valued Customers and Partners of Aquavit:

RE: Illegal Piracy Activities in Korea and China

Aquavit Pharmaceuticals, Inc. is a global ​life science company focusing on cutting edge technology. One of our technologies, micro channeling device "AQUAGOLD" is fully protected with worldwide perpetual licenses and overarching intellectual properties.



Continue Reading...

Dr. Mary Lupo Joins Aquavit Pharmaceuticals' Scientific Advisory Board

New York, NEW YORK, November 4, 2014

Aquavit Pharmaceuticals welcomes Mary Lupo, MD, FAAD as its newest Scientific Advisory Board member. Dr. Lupo is a board-certified dermatologist who is internationally recognized for non-surgical skin rejuvenation.

Continue Reading...

Aquavit Pharmaceuticals Announces Official Launch of AQUAGOLD® fine touch at the 72nd Annual Meeting of the American Academy of Dermatology

Denver, COLORADO, March 23, 2014

Aquavit Pharmaceuticals, Inc., a New York-based technology-driven life science company, officially launched its cutting-edge device, AQUAGOLD® fine touch today at the annual meeting for the American Academy of Dermatology, the world's largest dermatology meeting. AQUAGOLD® fine touchis an innovative device incorporating microneedles smaller than a human hair to deliver a substantial volume of medication directly into the dermis.

Continue Reading...

Aquavit Pharmaceuticals Appoints David J. Goldberg as Chief Medical Officer; Launching Its First Commercial Product, AQUAGOLD® fine touch at AAD

New York City, NEW YORK, March 5, 2014

Aquavit Pharmaceuticals, Inc., a private high-tech life science company, announced today the appointment of David J. Goldberg, MD., JD. as its Chief Medical Officer. Dr. Goldberg is a renowned dermatologist and is recognized nationally and internationally for his innovative work with skin lasers, cosmetic dermatology and facial rejuvenation techniques.

Continue Reading...

AQUAGOLD® fine touch showcased at 2014 South Beach Symposium

Miami Beach, FLORIDA, February 17, 2014

AQUAGOLD® fine touch was presented at the 2014 South Beach Symposium in Miami during a session on “What is New in Dermal Fillers". Dr. David Goldberg, Director, Skin Laser & Surgery Specialists of NY/NJ and Clinical Professor and Director of Laser Research in the Department of Dermatology at the Mount Sinai School of Medicine...

Continue Reading...

AQUAGOLD® fine touch Presented at the 2014 International Master Course on Aging Skin (IMCAS) by Dr. David Goldberg

Paris, FRANCE, February 5, 2014

AQUAGOLD® fine touch was featured at the 2014 International Master Course on Aging Skin Conference (IMCAS) in Paris during a session on “Clinical Evaluation of the Efficacy and Tolerance of Combining a Topical Tightening Agent with Devices" . Dr. David Goldberg, Director, Skin Laser & Surgery Specialists of NY/NJ and Clinical Professor and Director of Laser Research in the Department of Dermatology at the Mount Sinai School of Medicine, presented and discussed...

Continue Reading...

AQUAGOLD® fine touch featured at Winter Clinical Dermatology Meeting

Kohala Coast, HAWAII, January 19, 2014

AQUAGOLD® fine touch was featured at the 2014 Winter Clinical Dermatology Conference in Hawaii during a session on “New Procedures for the Aging Face”. Dr. Mark Nestor, Director of the Center for Cosmetic Enhancement® and Director of the Center for Clinical and Cosmetic Research in Aventura, Florida...

Continue Reading...

Aquavit Appoints David Shafer, MD., FACS., New Chief Medical Technology Officer

NEW YORK, March 4, 2013

Aquavit Pharmaceuticals Inc. has announced its newest addition to its management team, Dr. David Shafer. He has been appointed Chief Medical Technology Officer and will be leading Aquavit’s R&D Medical Technology for Aquavit’s product pipeline.

Continue Reading...

Dr. B.G. Rhee Joins Aquavit’s Advisory Board

SEOUL & NEW YORK, January 21, 2013

We are pleased to announce that Dr. B.G. Rhee has signed on as a member of Aquavit Pharmaceutical’s Advisory Board. The highly distinguished Dr. Rhee currently serves as the President of Green Cross Corp. (KOSPI: 006280), one of the leading biopharmaceutical companies in Korea.

Continue Reading...

Aquavit Pharmaceuticals Selects Uniquest for New High-Tech Medical Device Manufacturing

NEW YORK, December 12, 2012

Aquavit Pharmaceuticals, a privately held specialty pharmaceuticals and medical device company, has signed a term sheet with Uniquest Corporation (KOSPI:077500) for co-investment in the development, registration and manufacturing of Aquavit Pharmaceuticals’ PITO-001 and QVT-1009. The partnership will drive a breakthrough in personalized medicine with the use of advanced technologies.

Continue Reading...

Aquavit Pharmaceuticals and Uniquest sign MOU for Alliance Partnership

SEOUL & NEW YORK, October 8, 2012

Aquavit Life Sciences, Inc, a wholly owned subsidiary of Aquavit Pharmaceuticals, Inc, announces together with Uniquest Corporation (KOSPI:077500) a Memorandum Of Understanding to form an Alliance Partnership for the development, registration and manufacturing of Aquavit Pharmaceuticals’ PITO-001.

Continue Reading...

Aquavit Pharmaceuticals forms Alliance Partnership with Accelrys

NEW YORK, September 21, 2012

Aquavit Pharmaceuticals, Inc. and Accelrys Software Inc. (NASDAQ: ACCL), a leader in scientific innovation lifecycle management software, have formed an alliance partnership towards the development of Aquavit’s PITO-001 and MAV-403 products.

Continue Reading...

Aquavit and Green Cross sign Strategic Collaboration MOU on IBX-001 Product Development and Commercialization in Asia

SEOUL & NEW YORK, August 8, 2012

Aquavit Pharmaceuticals, Inc. and Green Cross Corp. (006280:Korea SE), a leading biotechnology company in South Korea, signed a Memorandum of Understanding (MOU) towards establishing their strategic collaboration surrounding the development and commercialization of Aquavit’s IBX-001 in Asia.

Continue Reading...

Video Interview with Dr Steven Fagien

NEW YORK, April 11, 2012

In a featured web article for the University of Florida, Dr. Steven Fagien was put under the Alumni Spotlight. Originally, philanthropic treatments had inspired him to become an oculoplastic cosmetic surgeon. Now he is a figurehead of the discipline.

Continue Reading...

Dr. Steven Fagien appointed as Chairman, Scientific Advisory Board

NEW YORK, February 1, 2012

Steve Fagien MD has joined us as Aquavit as chairman of the Scientific Advisory Board. As a world-class plastic surgeon he brings more than 25 years of clinical and development experience within the advanced field of facial aesthetics.

Continue Reading...

IMCAS Paris 2012

PARIS, FRANCE, January 30, 2012

Aquavit Pharmaceuticals, Inc. made its debut at IMCAS Paris on January 27, 2012. The company received a warm welcome from the European KOL community including Dr. Eric Auclair, President of ISPRES and Dr. Gino Rigotti, President of SOFCEP. “We don’t have anything like it in Europe.

Continue Reading...

Berkeley HAAS Business School invites Aquavit CEO on Innovation

NEW YORK, September 2, 2011

Sobin Chang, CEO joined MBA students and faculty members at HAAS Business School, University of California at Berkley on September 1st, 2011 on the topic of “Innovation”. She explored the concept of shared value – developing linkages between business strategies and product development – and how it can unleash the next wave of global growth and redefine capitalism within an organization. The event was followed by Q&As and luncheon.

Continue Reading...